Humana Downgraded by Deutsche Bank to Sell (HUM)
Humana (NYSE:HUM) was downgraded by investment analysts at Deutsche Bank from a “hold” rating to a “sell” rating in a note issued to investors on Tuesday, TheFlyOnTheWall.com reports. They currently have a $87.00 target price on the stock, down from their previous target price of $100.76. Deutsche Bank’s target price would indicate a potential downside of 13.48% from the stock’s previous close.
Other equities research analysts have also recently issued reports about the stock. Analysts at Zacks reiterated a “neutral” rating on shares of Humana in a research note to investors on Friday, December 6th. They now have a $107.00 price target on the stock. Separately, analysts at Morgan Stanley initiated coverage on shares of Humana in a research note to investors on Thursday, November 21st. They set an “equal weight” rating on the stock. Finally, analysts at JPMorgan Chase & Co. raised their price target on shares of Humana from $110.00 to $120.00 in a research note to investors on Wednesday, November 20th. They now have an “overweight” rating on the stock. Two analysts have rated the stock with a sell rating, twelve have assigned a hold rating and twelve have issued a buy rating to the stock. The company presently has an average rating of “Hold” and a consensus price target of $100.53.
Shares of Humana (NYSE:HUM) traded down 0.21% on Tuesday, hitting $100.55. 2,561,741 shares of the company’s stock traded hands. Humana has a 52 week low of $65.88 and a 52 week high of $105.80. The stock has a 50-day moving average of $102.1 and a 200-day moving average of $94.5. The company has a market cap of $15.677 billion and a P/E ratio of 11.10.
Humana (NYSE:HUM) last posted its quarterly earnings results on Wednesday, November 6th. The company reported $2.31 EPS for the quarter, beating the Thomson Reuters consensus estimate of $2.14 by $0.17. The company had revenue of $10.00 billion for the quarter, compared to the consensus estimate of $10.27 billion. During the same quarter in the prior year, the company posted $2.62 earnings per share. The company’s quarterly revenue was up 6.9% on a year-over-year basis. Analysts expect that Humana will post $8.75 EPS for the current fiscal year.
Humana Inc (NYSE:HUM) is a health care company.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.